JP2003512426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003512426A5 JP2003512426A5 JP2001532759A JP2001532759A JP2003512426A5 JP 2003512426 A5 JP2003512426 A5 JP 2003512426A5 JP 2001532759 A JP2001532759 A JP 2001532759A JP 2001532759 A JP2001532759 A JP 2001532759A JP 2003512426 A5 JP2003512426 A5 JP 2003512426A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- compound
- salt
- alkyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- UOOXDDHYFFXMJJ-LLVKDONJSA-N n-[(1r)-2,3-dihydro-1h-inden-1-yl]acetamide Chemical compound C1=CC=C2[C@H](NC(=O)C)CCC2=C1 UOOXDDHYFFXMJJ-LLVKDONJSA-N 0.000 description 3
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical class C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 description 2
- BKAZIFPIBFUJFU-UHFFFAOYSA-N 2-amino-n-(2,3-dihydro-1h-inden-1-yl)acetamide Chemical compound C1=CC=C2C(NC(=O)CN)CCC2=C1 BKAZIFPIBFUJFU-UHFFFAOYSA-N 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- -1 C 1 -C 4 alkyl Chemical class 0.000 description 2
- 206010026749 Mania Diseases 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- DBGKPDNKZZGWOM-JTQLQIEISA-N n-[(1s)-2,3-dihydro-1h-inden-1-yl]formamide Chemical compound C1=CC=C2[C@@H](NC=O)CCC2=C1 DBGKPDNKZZGWOM-JTQLQIEISA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16181799P | 1999-10-27 | 1999-10-27 | |
| US60/161,817 | 1999-10-27 | ||
| PCT/US2000/029618 WO2001030339A1 (en) | 1999-10-27 | 2000-10-27 | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003512426A JP2003512426A (ja) | 2003-04-02 |
| JP2003512426A5 true JP2003512426A5 (enExample) | 2007-12-27 |
Family
ID=22582876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001532759A Pending JP2003512426A (ja) | 1999-10-27 | 2000-10-27 | 双極性気分障害における躁病の治療のための1−アミノインダンの使用。 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6492426B1 (enExample) |
| EP (1) | EP1242066B1 (enExample) |
| JP (1) | JP2003512426A (enExample) |
| AT (1) | ATE331508T1 (enExample) |
| AU (1) | AU775885B2 (enExample) |
| CA (1) | CA2387394C (enExample) |
| DE (1) | DE60029131T2 (enExample) |
| IL (2) | IL149308A0 (enExample) |
| WO (1) | WO2001030339A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140090996A (ko) * | 2011-10-10 | 2014-07-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | R(+)-n-폼일-프로파길-아미노인단 |
| US9181026B2 (en) | 2013-10-03 | 2015-11-10 | Custom Chemical Solutions, LLC | Containment berm with internal “L” braces |
| WO2024196698A2 (en) * | 2023-03-17 | 2024-09-26 | Curadh Mtr | Compounds and constructs useful for targeting fibroblast activation protein |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB852735A (en) | 1956-04-13 | 1960-11-02 | Schering Ag | Manufacture of 1-aminoindanes |
| US3637740A (en) * | 1969-04-21 | 1972-01-25 | Pfizer | Aminobenzocycloalkane compounds |
| BE786748A (fr) * | 1971-07-26 | 1973-01-26 | Basf Ag | 1-aminomethyl-indanes-n-substitues |
| US4096173A (en) * | 1977-03-28 | 1978-06-20 | Eli Lilly And Company | Chlorinated 1-aminoindane N-methyl transferase inhibitors |
| JPS5824433A (ja) * | 1981-08-06 | 1983-02-14 | Takehiro Mokuzai Kogyo Kk | 繊維材成型品の表面化粧方法 |
| SE464194B (sv) | 1983-03-04 | 1991-03-18 | Otsuka Pharma Co Ltd | Indanderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner |
| EP0173331B1 (en) | 1984-08-31 | 1991-08-14 | Otsuka Pharmaceutical Co., Ltd. | 2,3-dihydro-1h-indene derivatives, a process for preparing them and pharmaceutical compositions containing same |
| US5242919A (en) | 1984-08-31 | 1993-09-07 | Otsuka Pharmaceutical Co., Ltd. | 2,3-dihydro-1H-indene derivatives |
| JPS6169747A (ja) | 1984-08-31 | 1986-04-10 | Otsuka Pharmaceut Co Ltd | 2,3―ジヒドロ―1h―インデン誘導体及びその製造法 |
| US4882339A (en) | 1987-07-10 | 1989-11-21 | Ciba-Geigy Corporation | 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals |
| US5744500A (en) | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| IL92952A (en) | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
| IL99759A (en) | 1991-10-16 | 1997-06-10 | Teva Pharma | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
| US5344836A (en) | 1991-11-11 | 1994-09-06 | Ono Pharmaceutical Co., Ltd. | Fused benzeneoxyacetic acid derivatives |
| CH683996A5 (fr) | 1992-03-05 | 1994-06-30 | Symphar Sa | Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant. |
| KR100238346B1 (ko) | 1993-04-07 | 2000-03-02 | 오쓰까 아끼히꼬 | 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제 |
| IL111240A (en) | 1993-10-18 | 2001-10-31 | Teva Pharma | Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them |
| AU1867095A (en) | 1994-01-10 | 1995-08-01 | Technion Research & Development Foundation Ltd. | 1-aminoindan derivatives and compositions thereof |
| US5877218A (en) | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| CH690264A5 (fr) | 1995-06-30 | 2000-06-30 | Symphar Sa | Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques. |
| US5646188A (en) | 1995-07-05 | 1997-07-08 | Teva Pharmaceutical Industries, Ltd. | Polyamine derivatives of 1-aminoindan |
| IL115357A (en) | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
| US5887218A (en) | 1996-06-10 | 1999-03-23 | Ricoh Co., Ltd. | Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof |
| DE69732984T2 (de) | 1996-12-18 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | Aminoindanderivate |
| US6251938B1 (en) | 1996-12-18 | 2001-06-26 | Teva Pharmaceutical Industries, Ltd., | Phenylethylamine derivatives |
| WO1998055447A1 (en) | 1997-06-05 | 1998-12-10 | Venantius Limited | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| US5887221A (en) | 1997-10-20 | 1999-03-23 | Xerox Corporation | Signature sensing for optimum toner control with donor roll |
| US6227886B1 (en) | 1999-04-16 | 2001-05-08 | Avaya Technology Corp. | Snag-resistant patchcord plug latch and cover |
-
2000
- 2000-10-27 EP EP00976661A patent/EP1242066B1/en not_active Expired - Lifetime
- 2000-10-27 AT AT00976661T patent/ATE331508T1/de not_active IP Right Cessation
- 2000-10-27 CA CA002387394A patent/CA2387394C/en not_active Expired - Fee Related
- 2000-10-27 JP JP2001532759A patent/JP2003512426A/ja active Pending
- 2000-10-27 IL IL14930800A patent/IL149308A0/xx active IP Right Grant
- 2000-10-27 AU AU14402/01A patent/AU775885B2/en not_active Ceased
- 2000-10-27 DE DE60029131T patent/DE60029131T2/de not_active Expired - Lifetime
- 2000-10-27 US US09/699,127 patent/US6492426B1/en not_active Expired - Fee Related
- 2000-10-27 WO PCT/US2000/029618 patent/WO2001030339A1/en not_active Ceased
-
2002
- 2002-04-23 IL IL149308A patent/IL149308A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003531118A5 (enExample) | ||
| JP2005515964A5 (enExample) | ||
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| JP2006506425A5 (enExample) | ||
| JP2004524316A5 (enExample) | ||
| JP2008509187A5 (enExample) | ||
| JP2004500426A5 (enExample) | ||
| JP2005519908A5 (enExample) | ||
| JP2005535592A5 (enExample) | ||
| JP2002520316A5 (enExample) | ||
| JP2005533860A5 (enExample) | ||
| JP2002502836A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JP2002527414A5 (enExample) | ||
| TW201912153A (zh) | 用於治療b型肝炎的化合物、醫藥組合物及方法 | |
| JP2001520994A5 (enExample) | ||
| JP2003512426A5 (enExample) | ||
| JP2011068661A (ja) | 洞房結節If電流阻害剤およびカルシウム阻害剤の新規な組み合わせならびにそれを含む医薬組成物 | |
| JP2004533415A5 (enExample) | ||
| JP5744003B2 (ja) | 抗ウイルス化合物を調製する方法 | |
| JP2008521934A5 (enExample) | ||
| JP2005513036A5 (enExample) | ||
| JP2001518468A5 (enExample) | ||
| JP2006510659A5 (enExample) | ||
| JP2002503724A5 (enExample) |